RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Elephas Biosciences

Elephas Biosciences

Provides a platform to predict immunotherapy response from live tumor biopsies.

Latest funding

$40M Series B+ ·

Led by ARCH Venture Partners · Source: fundraisingfox.com

Total raised: $95M across 2 sourced rounds

All 2 rounds ↓
Website: elephas.com.
Category: Health and bio.
Sectors: Artificial Intelligence (AI), Biotechnology, Health Care, Health Diagnostics, Medical.
Stage: Series B+.
Based in: Madison, United States.
Founded: 2020.
Total raised: $95M in 2 sourced rounds.
Last round: Nov 6, 2025 · 375 days ago.
Headcount: 101–250 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredMay 14, 2002 (24 years old)

Funding rounds

DateRoundAmountLeadSource
Series B+$40MAARCH Venture Partnersfundraisingfox.com
Series B+$55MCClarevia Venturesvcnewsdaily.com

Timeline

  1. Website created

Founders and team

Investors

Companies like Elephas Biosciences

Other companies backed by ARCH Venture Partners

ARCH Venture Partners portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/elephas-biosciences (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy